Star Sports Medicine shares surge 204% in Hong Kong debut

8 articles · Updated · Bloomberg · May 5

The medical-device maker rose to HK$299 from its HK$98.50 IPO price on Tuesday after raising HK$829.6 million.
Its retail tranche was subscribed more than 7,823 times, underscoring intense investor appetite for new listings in the city.
The jump extends a streak of strong first-day performances in Hong Kong, where debut trading frenzy has boosted newly listed stocks.

With its stock soaring 204%, can this new medical device star out-innovate its global rivals long-term?

Is China's self-reliance push creating real tech champions or just fueling a massive IPO bubble in Hong Kong?